FDAnews Drug Daily Bulletin

Aerie Pharmaceuticals Gets Good News on Glaucoma Treatment

Nov. 5, 2012
Soon, glaucoma patients may see relief from a single daily eye drop. Aerie Pharmaceuticals has announced positive top-line results for a Phase IIa study of its new glaucoma treatment — one that uses a once-daily dosage instead of multiple eye drops a day like current treatments.
Triangle Business Journal